Bausch Health US., LLC.
⚠️ Moderate Risk
FEI: 3010446985 • Bridgewater, NJ • UNITED STATES
FEI Number
3010446985
Location
Bridgewater, NJ
Country
UNITED STATESAddress
400 Somerset Corporate Blvd, , Bridgewater, NJ, United States
Moderate Risk
FDA Import Risk Assessment
This firm has a moderate history of FDA import refusals. Some attention may be warranted.
Statistics
Score Breakdown
How is this score calculated?
Proprietary Algorithm
- 40% Violation Severity — AI-assessed (1-10)
- 30% Refusal Volume — Logarithmic scale
- 20% Recency — Decays over 5 years
- 10% Frequency — Refusals per year
© ImportRefusal.com Original Analysis
Violation Summary
UNAPPROVED
The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).
NOT LISTED
It appears the drug or device is not included in a list required by Section 510(j), or a notice or other information respecting it was not provided as required by section 510(j) or 510(k).
DIRECTIONS
The article is subject to refusal of admission pursuant to section 801(a)(3) in that it is a device whose label appears to not bear adequate directions for use.
FRNMFGREG
The article is subject to refusal of admission pursuant to section 801(a)(3) in that it appears to be misbranded as defined in section 502(o) of the FD&C Act. It appears that it was manufactured, prepared, propagated, compounded, or processed in an establishment not duly registered under section 510 of the Act.
NO 510(K)
The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it is a post 1976 device for which a Section 510(k)application does not appear to have been determined substantially equivalent or otherwise filed.
Refusal History
| Date | Product | Violations | Division |
|---|---|---|---|
| 4/8/2024 | 61NCA05BUPROPION HCL (ANTI-DEPRESSANT) | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 9/26/2023 | 65RCY29TRETINOIN (REPLENISHER) | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 9/9/2019 | 86HQDLENS, CONTACT (OTHER MATERIAL) - DAILY | 118NOT LISTED | Division of Southeast Imports (DSEI) |
| 4/12/2019 | 62VDY18ACYCLOVIR (ANTI-VIRAL) | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 5/18/2018 | 86MUSFLUIDIC, PHACOEMULSIFICATION/PHACOFRAGMENTATION | Division of Southeast Imports (DSEI) | |
| 1/26/2016 | 62ODY28ENALAPRIL MALEATE (ANTI-HYPERTENSIVE - PART II) | 75UNAPPROVED | Division of Northern Border Imports (DNBI) |
Frequently Asked Questions
What is Bausch Health US., LLC.'s FDA import refusal history?
Bausch Health US., LLC. (FEI: 3010446985) has 6 FDA import refusal record(s) in our database, spanning from 1/26/2016 to 4/8/2024.
What is an FEI number?
FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Bausch Health US., LLC.'s FEI number is 3010446985.
What types of violations has Bausch Health US., LLC. received?
Bausch Health US., LLC. has been cited for 5 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.
Where does this information about Bausch Health US., LLC. come from?
All FDA import refusal data for Bausch Health US., LLC. is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.
Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.